Stay updated on Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.

Latest updates to the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe history now shows Revision: v3.5.4 as the latest entry, and Revision: v3.5.3 has been removed from the record history. This update reflects changes to the page's revision metadata rather than its substantive content.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision indicator has been updated from v3.5.2 to v3.5.3, reflecting a minor site/version maintenance update rather than a change to the clinical trial record itself.SummaryDifference0.1%

- Check36 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the study record history.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision: v3.5.0 was added to the history and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check72 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the history list. This update affects only the revision history entries on the page and does not alter study data or functionality.SummaryDifference0.1%

- Check100 days agoChange DetectedAddition of Revision: v3.4.2 and the removal of the funding/operating status notice are site-wide administrative updates. They do not change the study record, its data, or the core content of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.